Snowball logo
logo
ACT0

ALZCHEM GROUP N AG

ACT0 • XETRA
€159.40+€0.80  (0.5%)
Estimate
P/E
24
EPS
6.65
Beta
0.377
Growth
Revenue, YoY
7.31%
Net income, YoY
15%
FCF, YoY
-39.98%
Forecast
P/E (FWD)
19
EPS (FWD)
8.395
Dividends
Dividend yield
1.32%
Annual payout
€2.10
Next ex. div date
May 6, 27
Payout
31.58%
Div.growth, 5y
19.14%
Dividend growth streak
6 y
Div.rating
About the company
Ticker
ACT0
ISIN
Country
Germany
Sector (GICS)
Other
AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS " BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Frequently asked questions

What sector does ALZCHEM GROUP N AG (ACT0) operate in?

ALZCHEM GROUP N AG belongs to the Other sector and operates in the Specialty Chemicals industry.

What is ALZCHEM GROUP N AG (ACT0) current stock price?

As of the latest data, ALZCHEM GROUP N AG stock price is €159.40, with a previous close of €158.60. ALZCHEM GROUP N AG gained €0.80 in the last trading session, representing a 0.5% increase.

What is ALZCHEM GROUP N AG (ACT0) current market capitalization?

ALZCHEM GROUP N AG market cap is approximately 1.61 billion.

What is ALZCHEM GROUP N AG (ACT0) Earnings Per Share (EPS)?

The trailing EPS is €6.65, and the forward EPS is €8.40.

What is ALZCHEM GROUP N AG (ACT0) Price-to-Earnings (P/E) ratio?

ALZCHEM GROUP N AG current P/E ratio is 23.97, with a forward P/E of 18.99.

What is ALZCHEM GROUP N AG (ACT0) EBITDA?

ALZCHEM GROUP N AG EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 32.37 million.

Does ALZCHEM GROUP N AG (ACT0) pay dividends?

Yes. ALZCHEM GROUP N AG pays annual dividends with an annualized yield of 1.32% and an estimated annual payout of €2.10 per share.

When is the next ex-dividend date for ALZCHEM GROUP N AG (ACT0)?

The next ex-dividend date is scheduled for May 06, 2027.

When is ALZCHEM GROUP N AG (ACT0) next earnings report?

ALZCHEM GROUP N AG is expected to release its next earnings report on September 30, 2026.

What is ALZCHEM GROUP N AG (ACT0) beta (volatility) score?

ALZCHEM GROUP N AG has a beta of 0.377, indicating lower volatility than the overall market.